A roadmap for personalised prevention
Summary
The Cluster Health is under Pillar 2 of Horizon Europe. Its role is to advance knowledge and capabilities, improve understanding of health and diseases, develop innovative methodological and technological solutions to better manage health and diseases, as well as to design sustainable approaches for the digital transformation and delivery of integrated, person-centred and equitable health and care services.
Programme Name
Programme Description
Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.
Call
Detailed Call Description
Better co-ordination is essential to foster and accelerate the development and adoption of personalised prevention strategies for the years to come. It will also be important to assess the value of prevention in terms of savings in the health system.
Proposals should address all of the following:
- Identification and networking of key stakeholders for the co-creation of strategies for personalised prevention.
- Literature mapping, research gap analysis and mapping of existing research programmes for personalised prevention in Europe and beyond.
- Identification of existing bottlenecks, analysis of evidences and examples of successful implementation of personalised prevention approaches and assessment of their transferability.
- Analysis of how personalised prevention can be delivered most effectively, efficiently and cost-effective.
- Robust, professional communication strategy to maximise the impact of the findings and the uptake of personalised prevention strategies.
- A Strategic Research and Innovation Agenda on personalised prevention throughout the life course to inform research funders and other prospective partners of the expected future European partnership on personalised medicine.
Proposals should engage with related research initiatives and provide input to prospective partners of the expected future European partnership on personalised medicine.
Proposals should encourage a patient-centred approach that empowers patients, promotes a culture of dialogue and openness between health professionals, patients and their families, and unleashes the potential of social innovation.
Financing percentage by EU or other bodies / Level of Subsidy or Loan
100%
EU contribution per project:€ 3,00 million
Programme Category
EU Competitive ProgrammesTotal Budget
€3,00 millionThematic Categories
- Health
- Research, Technological Development and Innovation
Eligibility for Participation
- Researchers/Research Centers/Institutions
Call Opening Date
22/06/2021Call Closing Date
21/09/2021National Contact Point(s)
Research and Innovation Foundation
Marinos Fotiadis
Contact Phone: 22 205 048
E-mail: mphotiades@research.org.cy
Website: https://www.research.org.cy/
Ioannis Theodorou
Contact Phone: 22 205 038
E-mail: itheodorou@research.org.cy
Website: https://www.research.org.cy/
(Publish Date: 01/08/2021-for internal use only)
EU Contact Point
European Commission, Directorate-General for Research and Innovation
https://ec.europa.eu/info/departments/research-and-innovation_en#contact
